ArticleTherapeutic advances in medical oncology2024

Assessment of efficacy and safety of MET tyrosine kinase inhibitors in non-small-cell lung cancer patients with MET alterations.

Yanhua Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.